ANXA2 and breast cancer: In another study, phosphorylation at tyrosine 23 is required for ANXA2 activation, but knockdown of P-glycoprotein using small interference RNA in adriamycin-resistant breast cancer cell lines was found to significantly inhibit tyrosine phosphorylation of ANXA2.